Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): early-phase trial registry
1 of 3 indexed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 3 US clinical trials tracked, 1 recruiting.
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Immune Oncology Research Institute, running 1 of these trials.
Enrollment posture brief
Registry condition blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn
OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Immune Oncology Research Institute
NCT05430971
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Orca Biosystems
NCT04013685
Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
Stemline Therapeutics
NCT02113982
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Immune Oncology Research Institute sponsors the most Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) trials on record, review their full trial history before evaluating a specific study. See Immune Oncology Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) condition card totals 3 registered trials; most-linked intervention Orca-T; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.